Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone

AIMS: To investigate the magnitude of change in morning peak expiratory flow (PEF), asthma symptoms, and rescue β(2)-agonist use, when the aim of treatment is to achieve guideline-defined control. METHODS: This was a protocol-defined analysis of data from the previously-reported one-year, stratified...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Prim Care Respir J
Päätekijät: Woodcock, Ashley A, Bagdonas, Alfredas, Boonsawat, Watchara, Gibbs, Michael R, Bousquet, Jean, Bateman, Eric D
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2007
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6634212/
https://ncbi.nlm.nih.gov/pubmed/17551661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3132/pcrj.2007.00043
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia